| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Spinal cord injury 0.7309216579009724 2.406521853547183 0.016105240421276 0.9999262253091946 0.6146103541783422 15 P14174,P08670,P61586 3 |
| Proteasome degradation 0.6365438628051431 2.1986052664088382 0.0279060021805654 0.9999999373326552 0.6146103541783422 41 P28070,O75832,O00231,P61289,P49721,Q99436,P10321,P20618,P25787,P51665,P28074,P25789,P28072,P62191,P60900,Q99460,O43242,P25786,P01889,P49720 20 |
| Folate metabolism 0.7349354754631704 2.178381720879313 0.0293776296099057 0.99999997420867 0.6146103541783422 12 Q8WTV0,P00374,P34896,Q99707,P34897 5 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8473188702415065 2.0662129694351736 0.0388083747724152 0.9999999999155408 0.6146103541783422 5 P02545,Q03252,O60725,P49354 4 |
| Wnt signaling pathway and pluripotency 0.6979921658941333 1.996629019428862 0.0458654980177484 0.9999999999988748 0.6146103541783422 12 Q13363,P30154,P30153,P61586 4 |
| Neural crest cell migration in cancer 0.8147748947440551 1.9335315773708464 0.0531707469739028 0.9999999999999876 0.6146103541783422 5 P61586 1 |
| Calcium regulation in cardiac cells 0.6048679291640947 1.900797940520336 0.0573284839467871 0.999999999999999 0.6146103541783422 17 P61981,P08133,P27797,P62258,P10644,P05026,P63104,P0DP25,P27348,Q04917 10 |
| Myometrial relaxation and contraction pathways 0.6480485516089047 1.884719556233696 0.0594677106361649 0.9999999999999998 0.6146103541783422 14 Q05682,P61981,P62258,Q99439,P78417,P10644,P63104,P0DP25,P27348,Q04917 10 |
| Progeriaassociated lipodystrophy 0.700375402933307 1.883415454130866 0.0596440876247963 0.9999999999999998 0.6146103541783422 10 P46063,P02545,O75844,O60725,P49354,Q03252,P20700 7 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.7885536221830792 1.825409366247445 0.067939276940836 1.0 0.6146103541783422 5 P20337,Q9NR77,P04792 3 |
| Familial partial lipodystrophy fpld 0.7187602130834941 1.8189514830997404 0.0689188323320419 1.0 0.6146103541783422 7 P02545,O75844,O60725,P49354,Q03252 5 |
| Cellular proteostasis 0.8244680851063764 1.7285838820034536 0.0838835963912218 1.0 0.6610116573902147 4 Q9UHV9,O15212,Q99471 3 |
| Glycogen synthesis and degradation 0.5917068492512336 1.6535259537491824 0.0982238685034051 1.0 0.6694060382651738 15 Q15257,P0DP25,P30154,P30153 4 |
| Vitamin b12 metabolism 0.68568598829372 1.6326887483300094 0.102534475053885 1.0 0.6694060382651738 6 Q99707,Q8WTV0,P34897 3 |
| Striated muscle contraction pathway 0.8000613558241728 1.6310150923508553 0.1028871349827049 1.0 0.6694060382651738 4 P08670 1 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.6368085591535493 1.6296629243382017 0.1031727573805438 1.0 0.6694060382651738 11 P43490 1 |
| Cohesin complex cornelia de lange syndrome 0.6205321951468552 1.6048264172316713 0.1085320105729024 1.0 0.6694711389023243 12 P30154,P30153 2 |
| Adipogenesis 0.5919557864003674 1.5820585239118885 0.1136362108804449 1.0 0.6851568304643675 14 P43490,P14174,P17096 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5608225613589941 1.5552140932384395 0.1198950889243168 1.0 0.6956289317787098 16 Q9UPY3,O75844,O60725,P49354,Q9Y2U8,P55209,P42166 7 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.5668686573898387 1.5136158725657602 0.1301232930329121 1.0 0.7126378478251076 15 P16989,P08670 2 |
| Oxidation by cytochrome p450 0.7695684657649865 1.5083370014455724 0.1314682977395094 1.0 0.7133372451421529 4 P16435 1 |
| Male infertility 0.5212694377519485 1.4864377372495077 0.1371633742921434 1.0 0.724123759776541 18 P08183,Q9UHI6,P34896,Q15165,Q99707,P17096 6 |
| Wnt signaling pathway 0.6351746348397709 1.441351731746811 0.1494853392923718 1.0 0.7526372487573305 7 Q13363 1 |
| Mitochondrial complex iv assembly 0.6181067798072133 1.3992267603975432 0.1617449942324607 1.0 0.7636000963165617 8 P14406 1 |
| Netrinunc5b signaling pathway 0.5891621315581418 1.389903245279739 0.1645582600243171 1.0 0.7636000963165617 11 Q92859,P30154,P61586 3 |
| Pregnane x receptor pathway 0.7275319944205692 1.3382517331878805 0.1808143901400503 1.0 0.7636000963165617 4 P08183 1 |
| Fas ligand pathway and stress induction of heat shock proteins 0.5674577238939771 1.329676489411428 0.183624884317763 1.0 0.7637938638865934 12 P02545,Q03252,Q9UNN5,P20700 4 |
| Splicing factor nova regulated synaptic proteins 0.555847675214539 1.323191970003922 0.1857715457256976 1.0 0.7637938638865934 13 Q92859,Q06481 2 |
| Ras signaling 0.5196644904704626 1.313562835759556 0.1889933622244983 1.0 0.7637938638865934 16 P0DP25,P61586 2 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.7187375024583852 1.3025980794558063 0.1927120138053051 1.0 0.7707824568781667 4 P55263 1 |
| Ferroptosis 0.4633763373884786 1.2970621143414771 0.1946098156720224 1.0 0.7707824568781667 20 P16435,P45880,P02786 3 |
| Aryl hydrocarbon receptor pathway wp2873 0.6532779148192804 1.2544785736149195 0.2096681088799445 1.0 0.784269049762201 5 O00170,Q15185 2 |
| Ketogenesis and ketolysis 0.6521260669789937 1.2495657860172689 0.2114582079563614 1.0 0.784269049762201 5 O43772 1 |
| Cysteine and methionine catabolism 0.5967899742314722 1.235410868947734 0.2166776297318358 1.0 0.7924649429447341 6 Q99707 1 |
| Pi3kakt signaling pathway 0.4462619136728504 1.1834756679223528 0.2366206842209182 1.0 0.8252018367767484 26 P30154,P30153 2 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.5811574044393584 1.1650867014750088 0.243983899316849 1.0 0.8298529476480979 6 P63010,P61586 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5251750577214265 1.1581928602871563 0.2467853413054137 1.0 0.8298529476480979 13 O75822,P55010,P20042,P60228,P05198,O15372 6 |
| Influence of laminopathies on wnt signaling 0.550684137650578 1.1521994818800156 0.2492391105564253 1.0 0.8298529476480979 10 Q9UPY3,Q5JTV8,P02545,O75844,O60725,P49354 6 |
| Constitutive androstane receptor pathway 0.6264982225364957 1.1403326085197365 0.2541477575044664 1.0 0.8384178096514326 5 Q15257,P08183 2 |
| Glutathione metabolism 0.5753716615659216 1.139072331747142 0.2546729865494113 1.0 0.8384178096514326 6 P28161 1 |
| Burn wound healing 0.5524548457180817 1.0902625770012793 0.2755974950443904 1.0 0.8727756317775123 8 P08670 1 |
| Nad metabolism sirtuins and aging 0.804919848377211 1.046642241633058 0.2952646118133262 1.0 0.8727756317775123 3 P43490 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4835152822729187 1.037915567310438 0.2993093653290009 1.0 0.8761706974171805 15 P33176,P61586,Q9Y2U8 3 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5506248320496538 1.028055153319584 0.303923884602002 1.0 0.8761706974171805 6 P20339 1 |
| Mecp2 and associated rett syndrome 0.47069099428591 1.0240592365405343 0.3058072966167326 1.0 0.8761706974171805 16 P35637,Q13451,P67809,P31943 4 |
| Preimplantation embryo 0.5284204906028445 0.9514966645404054 0.3413523109212788 1.0 0.9029667190663356 7 Q99729 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.525413225024581 0.9378238690010662 0.3483349325017659 1.0 0.9029667190663356 7 P48506,O00170 2 |
| Regulation of actin cytoskeleton 0.4056019869649738 0.933203413268996 0.3507149527456683 1.0 0.9029667190663356 24 P18206,P35241,P35580,Q99570,Q13464,Q9Y281,Q9UQB8,P61586,P26038,P15311 10 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4912297114316212 0.93202242750823 0.3513249350633525 1.0 0.9029667190663356 12 Q96AY3,Q5JRA6,Q32P28,O75718 4 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6235173403700804 0.9193115993118384 0.3579326124801563 1.0 0.9080022117461972 4 P06730 1 |
| Exerciseinduced circadian regulation 0.4700510034268674 0.9090565737821568 0.3633202637690664 1.0 0.9176968731408316 14 Q12874,P25789,Q13185,Q16851,Q96PU8,Q00577 6 |
| Ccl18 signaling pathway 0.5030712974107187 0.836949875915272 0.4026207433680588 1.0 0.95501077920738 7 P08670,P33176 2 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.7327844029918962 0.7844710043551697 0.4327637892821276 1.0 0.980921000446477 3 P48506 1 |
| Endothelin pathways 0.4902685392846261 0.7798602576472303 0.4354731334087405 1.0 0.980921000446477 7 P42892,P00403 2 |
| Glycerophospholipid biosynthetic pathway 0.7218813905930386 0.7461766900169198 0.4555606872431432 1.0 0.980921000446477 3 O95674,O15228 2 |
| Methionine de novo and salvage pathway 0.4860473829437873 0.7438256375708512 0.4569819677847921 1.0 0.980921000446477 6 Q13126 1 |
| Disorders of folate metabolism and transport 0.4796882068097856 0.7331869725075749 0.4634443998927828 1.0 0.9875578848624392 7 Q99707,P00374 2 |
| Selenium micronutrient network 0.4686330862341116 0.7253366257105227 0.4682455417095661 1.0 0.9908918514231988 9 Q99707,Q8WTV0 2 |
| Copper homeostasis 0.5706073467388753 0.7140746413807301 0.4751810256658373 1.0 0.9908918514231988 4 P05067 1 |
| 3q29 copy number variation syndrome 0.4746992957277935 0.7113626088202684 0.4768595632913823 1.0 0.9908918514231988 7 P02786,P61088 2 |
| Wnt signaling 0.4636291915542618 0.6811434002127134 0.495780757649316 1.0 0.991561515298632 8 Q13363 1 |
| Pathogenic escherichia coli infection 0.3546525134728974 0.6326193506158172 0.5269822474904342 1.0 1.0 21 P19338,O15144,P63104,Q9BUF5,P61586,P27348,P15311 7 |
| Serine metabolism 0.4592608051363538 0.6306756782029165 0.5282526050978473 1.0 1.0 6 P00374,P34896 2 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.8135731807031914 0.6300515533870871 0.528660855153124 1.0 1.0 2 P09601 1 |
| Complement system 0.4416426874319215 0.6031387936503269 0.5464163609211694 1.0 1.0 9 P26885,P27797 2 |
| Complement system in neuronal development and plasticity 0.4495958607136655 0.5909233450263572 0.5545717833001282 1.0 1.0 6 Q5KU26,Q01518 2 |
| Amyotrophic lateral sclerosis als 0.4455923987081948 0.5869236712688205 0.5572549710858188 1.0 1.0 7 O96008,Q9BUN8,P20339 3 |
| Androgen receptor signaling pathway 0.3419785839760101 0.530585857856052 0.5957057978533675 1.0 1.0 22 Q02790,P61586 2 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.6561990726568896 0.5272377470751837 0.5980284987875555 1.0 1.0 3 P09601 1 |
| Hijack of ubiquitination by sarscov2 0.4739173842959615 0.5199613605320287 0.6030905064950547 1.0 1.0 5 Q8TBC4,Q13951 2 |
| Sarscov2 and covid19 pathway 0.6468023500775109 0.497983150634235 0.6184959182359986 1.0 1.0 3 Q8WTV0 1 |
| Onecarbon metabolism 0.3956652634546294 0.4859594014299362 0.6269959509113239 1.0 1.0 13 Q99707,P00374,P34896 3 |
| Prostaglandin synthesis and regulation 0.4169594935751152 0.4622023914785335 0.6439361884413939 1.0 1.0 6 P04083,P08133 2 |
| Translation factors 0.364576291445295 0.4547853565916029 0.6492636660774549 1.0 1.0 36 P11940,O75822,P55010,P20042,P60228,Q04637,O00303,Q9NR50,P05198,P23588,Q15056,P60842,Q05639,O15372,P06730,P62495,P63241 17 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3883840434517096 0.4281808418166651 0.6685194633104086 1.0 1.0 12 P61586 1 |
| Nanomaterial induced apoptosis 0.4881318664779019 0.4232455648624694 0.6721161057060372 1.0 1.0 4 O95831 1 |
| Microtubule cytoskeleton regulation 0.3788301405226059 0.4077926547346855 0.6834259066917137 1.0 1.0 13 Q9Y281,P16949,Q15691 3 |
| G13 signaling pathway 0.3746060393288 0.3683419111437336 0.7126183053092556 1.0 1.0 12 P61586 1 |
| Hedgehog signaling pathway wp47 0.7154538021259245 0.3521704570003897 0.724710431394479 1.0 1.0 2 O00422 1 |
| Pdgf pathway 0.3766161707332167 0.3462166348333029 0.7291799141109427 1.0 1.0 10 P61586 1 |
| Orexin receptor pathway 0.3648721930933714 0.3460583761305596 0.729298843995402 1.0 1.0 13 P31350,Q00059,P20290,P17096,P55145 5 |
| Glucocorticoid receptor pathway 0.4497868002544642 0.3080508578157501 0.7580436337695007 1.0 1.0 4 Q15185 1 |
| P53 transcriptional gene network 0.3693932148991866 0.2977401899914972 0.7659014665859731 1.0 1.0 7 P43246 1 |
| Disruption of postsynaptic signaling by cnv 0.3566029221572284 0.2556219335209628 0.7982427804577228 1.0 1.0 6 Q06787 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.3922203104812636 0.2538631210885569 0.7996013067127823 1.0 1.0 5 Q9H3P2 1 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.3143690695842446 0.2445274289428529 0.8068223613821845 1.0 1.0 30 P30154,P30153 2 |
| Vitamin b12 disorders 0.5487739069805231 0.2373336532961609 0.8123979562368961 1.0 1.0 3 Q99707 1 |
| Peroxiredoxin 2 induced ovarian failure 0.6627146361406437 0.2341876594407526 0.8148392950087711 1.0 1.0 2 P32119 1 |
| Vasopressinregulated water reabsorption 0.3368621519344386 0.2324238572547993 0.8162088208082579 1.0 1.0 13 Q9UJW0,Q13409,P20339 3 |
| Photodynamic therapyinduced unfolded protein response 0.3466384766946186 0.2315303463084438 0.8169028128641684 1.0 1.0 9 P27797 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.4197798667980572 0.2300904992808173 0.8180214473328651 1.0 1.0 4 P07099,P09601 2 |
| Nrf2are regulation 0.3470969559475244 0.2279154211287246 0.8197119938821065 1.0 1.0 6 P09601 1 |
| Nephrotic syndrome 0.341569757873385 0.2275122187396052 0.8200254691576814 1.0 1.0 11 O75844 1 |
| Onecarbon metabolism and related pathways 0.3392835934957259 0.2128716802604087 0.8314270519963003 1.0 1.0 10 Q99707,P34897,P34896 3 |
| Dna mismatch repair 0.3246529250467482 0.2003608123625791 0.8411984052327288 1.0 1.0 14 P28340,P43246,P41440 3 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3331791479017545 0.1992187483583716 0.8420916342902527 1.0 1.0 11 Q13363 1 |
| Type 2 papillary renal cell carcinoma 0.3366368816606561 0.1991976854805199 0.8421081098628942 1.0 1.0 6 Q92733 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.33568029772885 0.1966668018111164 0.8440882909973768 1.0 1.0 6 P06730 1 |
| Transsulfuration and onecarbon metabolism 0.314548148049281 0.1945643591326792 0.8457340070692165 1.0 1.0 16 Q99707,P00374,P34897,P34896 4 |
| Allograft rejection 0.3283181889883708 0.1758566417378668 0.8604065692904133 1.0 1.0 9 P08670 1 |
| Pathways affected in adenoid cystic carcinoma 0.3211923770558391 0.1672865569793515 0.8671445810687408 1.0 1.0 12 Q13363 1 |
| Apoptosis modulation and signaling 0.3214432144321524 0.1566720687052361 0.875503301135818 1.0 1.0 9 P04637,Q9Y3E5,O95831,Q9NR28,P27361,Q9H0E2,Q07812,O00273 8 |
| Alzheimers disease 0.3950130835734072 0.1544237693420965 0.8772756132194341 1.0 1.0 74 Q00535,Q92542,P28070,P07384,O95197,Q9UNM6,Q99570,P49721,Q99436,Q9BUF5,P20618,P0DP25,P25787,P21796,P51665,P28074,P25789,P28072,P05198,P62191,P60900,P05067,Q99460,O43242,P45880,P25786,P33176,P12235,P49720 29 |
| Ectoderm differentiation 0.3012784182998804 0.1428499837514346 0.886408660519101 1.0 1.0 16 Q13363 1 |
| Mitochondrial gene expression 0.3714282860817379 0.1306713636215926 0.8960352865877794 1.0 1.0 4 Q00059 1 |
| Apoptosis 0.306135189396608 0.1224863157904183 0.902513882805708 1.0 1.0 7 Q99590 1 |
| Eicosanoid synthesis 0.5923957481602699 0.119271418161593 0.905060326836455 1.0 1.0 2 Q9H7Z7 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3016193910092714 0.1174779199544782 0.9064813401985888 1.0 1.0 6 O14786,O14646 2 |
| Leukocyteintrinsic hippo pathway functions 0.481141297123112 0.1170414655581055 0.906827194508206 1.0 1.0 3 P61586 1 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.5878986099754784 0.1136185808423755 0.909540157352696 1.0 1.0 2 Q9P2K5 1 |
| Estrogen receptor pathway 0.5878986099754784 0.1136185808423755 0.909540157352696 1.0 1.0 2 Q15067 1 |
| Alzheimers disease and mirna effects 0.3868242343100116 0.1075441334363513 0.9143573148995852 1.0 1.0 75 Q00535,Q92542,P28070,P07384,O95197,Q9UNM6,Q99570,P49721,Q99436,Q9BUF5,P20618,P0DP25,P25787,P21796,P51665,P28074,P25789,P28072,P05198,P62191,P60900,P05067,Q99460,O43242,P45880,P25786,P33176,P12235,P49720 29 |
| Mitochondrial complex i assembly model oxphos system 0.2716360445338988 0.1057501079561815 0.915780622810356 1.0 1.0 20 O96000,Q8N183,O75380,O43676,O95168 5 |
| Nocgmppkg mediated neuroprotection 0.5789043336058955 0.1029076298262104 0.9180362821281032 1.0 1.0 2 P35609 1 |
| Nucleotide metabolism 0.2954809332951761 0.0922953182020307 0.9264634080281724 1.0 1.0 12 P31350,P11908,P22392,P00374,P28340 5 |
| Small cell lung cancer 0.288816058992212 0.0877126988492003 0.9301050263049996 1.0 1.0 7 P04637,P63208,P05556,P11802,P06400,Q07812 6 |
| Primary focal segmental glomerulosclerosis fsgs 0.2842000101644897 0.0836479077561292 0.9333363754980446 1.0 1.0 16 P08670 1 |
| Hif1a and pparg regulation of glycolysis 0.4498977505112511 0.0793672113180998 0.936740547923838 1.0 1.0 3 P04406,P00338 2 |
| Nucleotidebinding oligomerization domain nod pathway 0.3334533789420387 0.0764277323096159 0.9390788069326096 1.0 1.0 4 P07900 1 |
| Tumor suppressor activity of smarcb1 0.2867238797205287 0.0704278308712512 0.9438531404089928 1.0 1.0 12 Q8TAQ2,O14497 2 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.2719082719082673 0.0662590449628077 0.9471715889216346 1.0 1.0 6 O43684,O60216,O60566,Q9UQE7,O43683 5 |
| Fragile x syndrome 0.2818754225241664 0.047044035878151 0.962478130804978 1.0 1.0 34 Q96B36,Q06787,Q9UPY3,Q04637,P53985,P50570,P06730,P63010,P05067 9 |
| Oxidative damage response 0.5061324611610902 0.0428643413373561 0.9658096741009692 1.0 1.0 2 P12004 1 |
| Prostaglandin and leukotriene metabolism in senescence 0.4926410466067133 0.0362052963126296 0.9711186629131312 1.0 1.0 2 P09960 1 |
| Ciliopathies 0.2684991956964702 0.0337440972556452 0.9730812144541948 1.0 1.0 11 O43924,Q9UBB4,Q15555,Q10713 4 |
| Mammary gland development pathway involution stage 4 of 4 0.3856850715746421 0.032776055397556 0.9738531729758716 1.0 1.0 3 P40763,Q07812 2 |
| Integrinmediated cell adhesion 0.269788425506761 0.0324355577897668 0.9741247063816104 1.0 1.0 13 Q13464,P07384,Q15942 3 |
| Complement and coagulation cascades 0.4685200327064714 0.0269915317838797 0.9784664882297484 1.0 1.0 2 P49257 1 |
| Leptininsulin signaling overlap 0.4546197874080211 0.0230202296860778 0.9816341362683458 1.0 1.0 2 P40763 1 |
| Riboflavin and coq disorders 0.3887980376124363 0.0132596042416264 0.9894206764984964 1.0 1.0 2 Q16134 1 |
| Tp53 network 0.3855273916598593 0.0130382830013263 0.9895972500337736 1.0 1.0 2 Q07812 1 |
| Sudden infant death syndrome sids susceptibility pathways 0.2456219154754802 0.0072630007042792 0.994205014821717 1.0 1.0 23 P61981,P42892,P62258,P67809,P10644,P63104,P12235,P31946,P27348,Q04917 10 |
| Nucleotide excision repair 0.2568112838932282 0.0053632631959895 0.9957207556155274 1.0 1.0 15 P28340,P41440,P54727 3 |
| Tgfbeta signaling pathway 0.2589185420846997 0.0048215381344531 0.996152984068614 1.0 1.0 29 P61586 1 |
|
|
